Full List Of Stories
US close: Stocks close higher ahead of trade deal signing
Wall Street stocks closed higher on Monday as market participants cheered news that the US would be removing China from a list of currency manipulators ahead of the pair's "phase one" trade deal later in the week.
US open: Positive start trading as US-China trade returns to focus
Wall Street stocks opened higher on Monday as market participants awaited the signing of the US and China's "phase one" trade deal later in the week.
Broker tips: Ted Baker, Man Group, JD Sports
RBC Capital Markets downgraded its recommendation on Ted Baker on Monday as it took a look at premium apparel stocks.
Director dealings: NMC Health vice-chairman lowers stake
NMC Health revealed on Monday that vice-chairman Khaleefa Butti Omair Yousif Ahmed Al Muhairi had disposed of 4. 64m ordinary shares in the UAE-based healthcare firm.
Berenberg raises target price on JD Sports
Analysts at Berenberg raised the target price on retailer JD Sports from 860. 0p to 950. 0p on Monday following another "impressive performance" against a challenging retail backdrop.
Caretech appoints Christopher Dickinson as CFO
Social care services provider Caretech tapped Christopher Dickinson to take over as chief financial officer of the group on Monday, with immediate effect.
US pre-open: Futures point to early gains ahead of 'phase one' trade deal
Wall Street futures had stocks opening higher on Monday as market participants awaited the signing of the US and China's "phase one" trade deal later in the week.
Instem revenues continue to grow as SaaS transition progresses
IT solutions provider Instem said on Monday that revenues had continued to grow during 2019 as a result of the group's pivot towards a more software-as-a-service based model.
Quartix expects FY revenues and profits to top forecasts
Vehicle tracking firm Quartix expects full-year revenues, profits and free cash flow to be "slightly ahead" of current market forecasts.
Vectura sees FY revenues and earnings 'at least' in line with expectations
Pharmaceuticals company Vectura said on Monday that its base business had continued to perform well in 2019.
Hikma inks exclusive agreement with Chiesi Farmaceutici
British pharmaceutical company Hikma has inked an exclusive licensing and distribution agreement with Chiesi Farmaceutici, a research-focused business headquartered in Italy.
Assura makes 'strong' progress in Q3
Primary care property investor Assura told investors on Monday that it had continued to make "strong progress" during the third quarter.